Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

The evolution of lab management: A deep dive into OI view with Oxford Instruments

Discover how OI View delivers real-time insights, revolutionizes lab management, and enhances productivity for Oxford Instruments users.

From Oxford Instruments - Life Sciences 15 Oct 2024

Innovative bacteria-based therapy shows promise against cancer

Even as cancer remains a leading cause of death globally, bacteria-based cancer therapy presents an exciting and innovative treatment option.

15 Oct 2024

New vial size could save Medicare millions on Alzheimer's drug

Medicare could save up to 74% of the money lost from discarded Alzheimer's drug lecanemab by the simple introduction of a new vial size that would reduce the amount of unused medication that is thrown away, new research suggests.

14 Oct 2024

InnoProtein launches ProteinPioneers for sustainable alternatives

Ahead of World Algae Day (12th October), the EU-Funded project InnoProtein will celebrate the occasion by launching the #ProteinPioneers initiative. Europe faces a significant "protein gap," importing 70% of its protein-rich crops and 85% of its soybeans for both animal and human consumption.

12 Oct 2024

Cell stress from crowding leads to slower growth and circular patterns

Like so many organisms on the planet, when cells experience mosh-pit-level crowding, they may just become stressed. Yet unlike most other life forms, cells subject to physical stress from crowding by neighbors can find some relief by dramatically slowing their own growth - and in doing so form an eye-catching pattern of concentric circles as a spectacular consequence.

12 Oct 2024

MaxCyte appoints Ali Soleymannezhad as Chief Commercial Officer

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bioprocessing applications, today announced the appointment of Ali Soleymannezhad as Chief Commercial Officer, effective as of September 11, 2024.

From MaxCyte, Inc. 11 Oct 2024

Breakthrough in mirror molecule synthesis opens doors for drug discovery

A University of Texas at Dallas chemist and his colleagues have developed a new chemical reaction that will allow researchers to synthesize selectively the left-handed or right-handed versions of "mirror molecules" found in nature and assess them for potential use against cancer, infection, depression, inflammation and a host of other conditions.

10 Oct 2024

Bedfont® Scientific Limited Triumphs at Chamber Business Awards, Winning Business of the Year 2024

...

From Bedfont® Scientific Ltd 9 Oct 2024

African nations must take ownership of HIV response to reduce disease burden

Africa must take ownership of its HIV response, write Izukanji Sikazwe and Magda Robalo, co-chairs of the African-led HIV Control Working Group.

9 Oct 2024

Transparency and rigorous oversight urged for U.S. Medicare Advantage program

New findings from a team of renowned researchers calls for transparency and rigorous oversight of the U.S. Medicare Advantage (MA) program, the United States' largest healthcare capitation program.

8 Oct 2024

USC's Keck School of Medicine partners with StemCardia to advance heart failure treatment

The Keck School of Medicine of USC has launched a strategic collaboration with StemCardia, a biotechnology company, founded by a Keck School of Medicine faculty member, that develops cellular and genetic therapies to address heart failure.

8 Oct 2024

Unexpected benzene levels in popular acne and rosacea products

Investigators have determined that a substantial portion of topical benzoyl peroxide (BPO) acne and rosacea treatments currently on the market are unstable and contain unacceptably high levels of benzene, a known human carcinogen.

7 Oct 2024

Innovative immunotherapy harnesses natural killer T cells to combat solid tumors

In the fight against cancer, chimeric antigen receptor T cell (CAR-T) therapy has achieved notable success in treating blood cancers. However, it has been largely ineffective against solid tumors.

7 Oct 2024

Ingenza announces move to purpose-built facilities to expand fermentation and research capacity

Ingenza – a world-leading contract research, development and manufacturing organisation (CRDMO) and technology accelerator – is delighted to announce its plans to relocate to the Moubray Building at Edinburgh Technopole, part of Pioneer Group. Following a detailed strategic review, the company has embarked on the creation of a multi-million pound facility to help drive its ambitious growth plans. The purpose-built premises will more than double Ingenza’s current footprint to approximately 25,000 square feet, expanding its fermentation and research facilities.

From Ingenza Ltd 7 Oct 2024

Rice University leads development of innovative bioelectronic implant for obesity and diabetes

Rice University is part of a multiuniversity research team that has secured an award of up to $34.9 million from the Advanced Research Projects Agency for Health (ARPA-H) to accelerate the development of a bioelectronic implant designed to improve adherence for obesity and type 2 diabetes (T2D) treatment while reducing development and manufacturing costs.

3 Oct 2024

FDA approves new PET imaging agent for coronary artery disease

The U.S. Food and Drug Administration (FDA) has approved flurpiridaz F-18 (Flyrcado; GE Healthcare), a first-of-its-kind positron emission tomography (PET) imaging agent, for use in adult patients with known or suspected coronary artery disease (CAD).

1 Oct 2024